1. Home
  2. SLE vs DRMA Comparison

SLE vs DRMA Comparison

Compare SLE & DRMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Super League Enterprise Inc.

SLE

Super League Enterprise Inc.

HOLD

Current Price

$4.06

Market Cap

5.6M

ML Signal

HOLD

Logo Dermata Therapeutics Inc.

DRMA

Dermata Therapeutics Inc.

HOLD

Current Price

$1.24

Market Cap

5.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SLE
DRMA
Founded
2014
2014
Country
United States
United States
Employees
N/A
9
Industry
Services-Misc. Amusement & Recreation
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.6M
5.1M
IPO Year
2019
N/A

Fundamental Metrics

Financial Performance
Metric
SLE
DRMA
Price
$4.06
$1.24
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
1
Target Price
$60.00
$10.00
AVG Volume (30 Days)
11.1K
57.7K
Earning Date
05-14-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$2,064,000.00
N/A
Revenue This Year
$24.86
N/A
Revenue Next Year
$49.77
$650.00
P/E Ratio
N/A
N/A
Revenue Growth
90.41
N/A
52 Week Low
$0.10
$0.59
52 Week High
$11.43
$7.33

Technical Indicators

Market Signals
Indicator
SLE
DRMA
Relative Strength Index (RSI) 57.20 44.30
Support Level $3.92 $1.13
Resistance Level $4.54 $1.40
Average True Range (ATR) 0.30 0.08
MACD 0.04 -0.00
Stochastic Oscillator 95.30 18.23

Price Performance

Historical Comparison
SLE
DRMA

About SLE Super League Enterprise Inc.

Super League Enterprise Inc is the rocket ship to the metaverse. It is a creator and publisher of content experiences and media solutions across the globe's immersive platforms. Its solutions provide incomparable access to massive audiences that gather in immersive digital spaces to socialize, play, explore, collaborate, shop, learn, and create. The company offers a complete range of development, distribution, monetization, and optimization capabilities designed to engage users through dynamic, energized programs. It generates revenue from advertising, including immersive game world and experience publishing and in-game media products, direct-to-consumer offers, including in-game items, e-commerce, game passes and ticketing and digital collectibles, and content and technology.

About DRMA Dermata Therapeutics Inc.

Dermata Therapeutics Inc develops and commercializes dermatology products for the treatment of common skin conditions. It focuses on leveraging prior clinical and technical expertise to develop OTC treatments for conditions such as acne, psoriasis, rosacea, and seborrheic dermatitis. The company is currently developing a once-weekly acne treatment system that utilizes an active ingredient from the OTC monograph in combination with the company's Spongilla technology. It intends to apply its Spongilla technology platform across a range of dermatologic and aesthetic skin applications, including intradermal delivery of botulinum toxin. The company's operates in one segment, which is the business of developing, branding, marketing, and commercializing direct to consumer skincare products.

Share on Social Networks: